바스테라, 시리즈B 180억 "레독스 심혈관·암 신약개발"

http://www.biospectator.com/view/news_view.php?varAtcId=15649&fbclid=IwAR0TkqELtWUSUe7AwgNLY2TOdTHNrFaR3uKD9bPYVSE0boThgxPpM2vGQNA